Roivant Market Capitalization from 2010 to 2024
| ROIV Stock | USD 12.46 0.07 0.56% |
Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 20.9 M or Interest Expense of 36.5 M, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 6.0E-4 or PTB Ratio of 2.04. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.
Roivant | Market Capitalization |
Latest Roivant Sciences' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Roivant Sciences over the last few years. It is Roivant Sciences' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 9.07 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Roivant Market Capitalization Regression Statistics
| Arithmetic Mean | 3,329,351,176 | |
| Geometric Mean | 2,971,310,632 | |
| Coefficient Of Variation | 57.31 | |
| Mean Deviation | 1,455,672,852 | |
| Median | 2,239,673,446 | |
| Standard Deviation | 1,908,202,611 | |
| Sample Variance | 3641237.2T | |
| Range | 5.9B | |
| R-Value | 0.68 | |
| Mean Square Error | 2100650.8T | |
| R-Squared | 0.46 | |
| Significance | 0.01 | |
| Slope | 290,743,266 | |
| Total Sum of Squares | 50977320.9T |
Roivant Market Capitalization History
About Roivant Sciences Financial Statements
Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.